Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This study was a multicenter, randomized, PROBE-type (prospective, randomized, open label,
blinded end-point) study of 12 weeks duration comprising four visits, carried out in patients
with essential arterial hypertension not controlled on four weeks treatment with amlodipine 5
mg alone.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Amlodipine Amlodipine, Valsartan Drug Combination Valsartan